Search
Find a recruiting study
7,114 recruiting studies with US sites, from the official ClinicalTrials.gov registry (refreshed Oct 28, 2026). No sign-up needed.
Most recently updated studies · page 94 of 297
- RecruitingPhase 1/Phase 2
Evaluation of Intra-articular CX-011 to Treat Moderate to Severe Pain From Knee Osteoarthritis
CarthroniX, Inc.
- Location
- Los Angeles, CA
- Eligibility basics
- Ages 40–75
- RecruitingPhase 2
Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH
Madrigal Pharmaceuticals, Inc.
- Location
- La Jolla, CA + 11 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study of Depemokimab in Participants of 6 to 11 Years of Age
GlaxoSmithKline
- Location
- Mobile, AL + 2 other US sites
- Eligibility basics
- Ages 6–11
- Recruiting
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Procyrion
- Location
- Phoenix, AZ + 31 other US sites
- Eligibility basics
- Ages 21+
- RecruitingPhase 3
A Study of Pitolisant in Patients With Prader-Willi Syndrome
Harmony Biosciences Management, Inc.
- Location
- Los Angeles, CA + 18 other US sites
- Eligibility basics
- Ages 6+
- RecruitingPhase 3
A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies
Pfizer
- Location
- Glendale, AZ + 1 other US site
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Immunovant Sciences GmbH
- Location
- Phoenix, AZ + 54 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)
Relay Therapeutics, Inc.
- Location
- Phoenix, AZ + 21 other US sites
- Eligibility basics
- Ages 2+
- RecruitingPhase 2
A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the Knee
Pacira Pharmaceuticals, Inc
- Location
- Huntington Beach, CA + 2 other US sites
- Eligibility basics
- Ages 45–80
- RecruitingPhase 2
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Immunovant Sciences GmbH
- Location
- Tucson, AZ + 32 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
Assessment of CSF Shunt Flow During Activities of Daily Living and Sleep With a Thermal Measurement Device
Rhaeos, Inc.
- Location
- Chicago, IL + 1 other US site
- Eligibility basics
- Ages 2+
- RecruitingPhase 1
An Open-label Study of AZD0120 in Adults With Multiple Sclerosis
AstraZeneca
- Location
- Washington D.C., DC + 4 other US sites
- Eligibility basics
- Ages 18–60
- RecruitingPhase 2
Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants Undergoing Open Abdominal Ventral Hernia Repair
AbbVie
- Location
- Riverside, CA + 10 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2
Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformations in Participants 6 Months to Less Than 18 Years of Age
Protara Therapeutics
- Location
- Birmingham, AL + 8 other US sites
- Eligibility basics
- Ages 6 mo–18
- RecruitingPhase 1/Phase 2
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
UniQure Biopharma B.V.
- Location
- Birmingham, AL + 15 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 1
A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
Eli Lilly and Company
- Location
- Maitland, FL + 4 other US sites
- Eligibility basics
- Ages 50–85
- RecruitingPhase 1
Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B
Precision BioSciences, Inc.
- Location
- Boston, MA
- Eligibility basics
- Ages 18–70
- RecruitingPhase 2/Phase 3
Study of Choline Chloride for Injection in Adolescent and Adult Patients With Intestinal Failure Receiving Long Term Parenteral Support
Protara Therapeutics
- Location
- Aurora, CO + 5 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 1
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia
AstraZeneca
- Location
- Glendale, CA + 5 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
AstraZeneca
- Location
- Athens, AL + 206 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)
Autolus Limited
- Location
- New York, NY + 2 other US sites
- Eligibility basics
- Ages 12–65
- Recruiting
Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease
MMI (Medical Microinstruments, Inc.)
- Location
- Palo Alto, CA + 2 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 2
Safety and Efficacy of J147 in Acute Ischemic Stroke
Abrexa Pharmaceuticals, Inc.
- Location
- Rockford, IL
- Eligibility basics
- Ages 18–90
- RecruitingPhase 3
A Phase III Study to Evaluate the Efficacy and Safety of Libevitug in Participants With Chronic HDV Infection (D-clear Study)
Huahui Health
- Location
- Garden Grove, CA
- Eligibility basics
- Ages 12–70
Data source: daily sync of the ClinicalTrials.gov API. How we list studies